Cogent Biosciences Inc (NASDAQ: COGT) kicked off on Friday, up 5.17% from the previous trading day, before settling in for the closing price of $40.04. Over the past 52 weeks, COGT has traded in a range of $3.72-$43.73.
During the last 5-year period, the sales growth of Healthcare Sector giant was 10.02%. While this was happening, its average annual earnings per share was recorded 8.10%. With a float of $125.26 million, this company’s outstanding shares have now reached $139.83 million.
Cogent Biosciences Inc (COGT) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Cogent Biosciences Inc is 17.62%, while institutional ownership is 87.34%. The most recent insider transaction that took place on Jul 10 ’25, was worth 24,999,993. In this transaction Director of this company bought 2,777,777 shares at a rate of $9.00, taking the stock ownership to the 9,003,418 shares. Before that another transaction happened on Jan 14 ’25, when Company’s Chief Commercial Officer bought 43,750 for $7.60, making the entire transaction worth $332,412. This insider now owns 45,848 shares in total.
Cogent Biosciences Inc (COGT) Earnings and Forecasts
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.09 earnings per share (EPS), higher than consensus estimate (set at -0.58) by 0.49. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.49 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 8.10% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 44.75% during the next five years compared to 10.02% growth over the previous five years of trading.
Cogent Biosciences Inc (NASDAQ: COGT) Trading Performance Indicators
Take a look at Cogent Biosciences Inc’s (COGT) current performance indicators. Last quarter, stock had a quick ratio of 6.38.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.37, a number that is poised to hit -0.52 in the next quarter and is forecasted to reach -1.78 in one year’s time.
Technical Analysis of Cogent Biosciences Inc (COGT)
Looking closely at Cogent Biosciences Inc (NASDAQ: COGT), its last 5-days average volume was 3.1 million, which is a jump from its year-to-date volume of 2.26 million. As of the previous 9 days, the stock’s Stochastic %D was 44.98%.
During the past 100 days, Cogent Biosciences Inc’s (COGT) raw stochastic average was set at 95.14%, which indicates a significant increase from 76.92% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.12 in the past 14 days, which was higher than the 1.13 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $26.09, while its 200-day Moving Average is $12.96. However, in the short run, Cogent Biosciences Inc’s stock first resistance to watch stands at $43.15. Second resistance stands at $44.18. The third major resistance level sits at $46.13. If the price goes on to break the first support level at $40.17, it is likely to go to the next support level at $38.22. Should the price break the second support level, the third support level stands at $37.19.
Cogent Biosciences Inc (NASDAQ: COGT) Key Stats
The company with the Market Capitalisation of 6.40 billion has total of 142,377K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -255,860 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -80,930 K.
